Company GlobeImmune Inc Nasdaq
Equities
US37957B1008
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2014 | Weight | 2015 | Weight | Delta |
---|---|---|---|---|---|
Biopharmaceutical Products
100.0
%
| 6 | 100.0 % | 6 | 100.0 % | +8.24% |
Sales per region
USD in Million | 2014 | Weight | 2015 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 6 | 100.0 % | 6 | 100.0 % | +8.24% |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Augustine Lawlor
BRD | Director/Board Member | 67 | 31/05/03 |
Ehud Geller
BRD | Director/Board Member | 77 | - |
Charles C. Kim
BRD | Director/Board Member | - | - |
Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 5,751,574 | 5,751,574 ( 100.00 %) | 0 | 100.00 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+38.61% | 12.63B | |
+313.59% | 8.49B |